Rite Aid Corporation stock price, RAD

Rite Aid Corporation stock chart:



Rite Aid Corporation close price: 3.95

Stock price forecast:

UP TO +1.01%
Target: 3.99

Total forecasts: 85
Reached: 11 (12.94%)

Total Win: 1.27 (32.58%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90851112.94%1.270.38%303.54-11.24-3.70%-9.97-2.88%
303100.00%0.000.00%122.450.000.00%0.000.00%
141500.00%0.000.00%59.250.000.00%0.000.00%
7800.00%0.000.00%31.600.000.00%0.000.00%

Showing 1-10 of 596 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-06-263.953.990000-00-00
2017-06-253.953.990000-00-00
2017-06-243.953.990000-00-00
2017-06-233.953.990000-00-00
2017-06-223.954.030000-00-00
2017-06-213.954.030000-00-00
2017-06-203.954.020000-00-00
2017-06-193.954.030000-00-00
2017-06-183.954.050000-00-00
2017-06-173.954.050000-00-00

Rite Aid Corporation latest news:


  • 06/09/2017 11:32:02

    UPDATE 1-FTC staff to advise blocking Walgreens deal to buy Rite Aid -Capitol Forum

    June 9 (Reuters) - The Federal Trade Commission's staff is prepared to recommend that the agency sue to stop Walgreens Boots Alliance Inc from buying rival drugstore chain Rite Aid Corp, policy news company Capitol Forum reported on Friday.

  • 06/09/2017 10:48:09

    FTC to advise blocking Walgreens deal to buy Rite Aid - CNBC

    June 9 (Reuters) - Regulatory authorities are set to advise blocking U.S. drugstore chain Walgreens Boots Alliance Inc's deal to buy smaller rival Rite Aid Corp, CNBC reported on Friday, citing a report.

  • 06/09/2017 07:42:07

    Pandora to sell Ticketfly for $200 million

    Pandora Media Inc. announced Friday a $200 million deal to sell its Ticketfly business to Eventbrite, which includes $150 million in cash and a $50 million note payable to Pandora. The announcement comes after Sirius XM Holdings Inc. announced a deal to make a $480 million investment in Pandora, through the purchase of Series A preferred stock. Pandora said it expects the Ticketfly deal to close in the third-quarter of 2017. Separately, Pandora affirmed its second-quarter revenue outlook of $360 million to $375 million and its 2017 outlook of $1.50 billion to $1.65 billion. "Pandora is now poised to advance to the next stage of the company's lifecycle," said Pandora Director Tim Leiweke. "We are pleased that the conclusion of our strategic review resulted in a major investment by a world class company like SiriusXM, and with the sale of Ticketfly, we will now redouble our focus on execution supported by a strong balance sheet." The stock surged 3.9% in morning trade, but has tumbled 33% year to date, while the S&P 500 has gained 8.9%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 06/06/2017 14:11:52

    Exact Sciences stock falls after share offering

    Shares of Exact Sciences Corp. fell more than 3% Tuesday after the company said it entered an agreement with Jefferies LLC, Bank of America Merrill Lynch, and Robert W. Baird & Co. to sell 7 million shares of its common stock. The underwriters will also have an option to buy additional shares. The company intends to use the net proceeds of this offering to fund its expansion, including to increase laboratory, manufacturing and customer service capacity, to fund product development efforts, and for general corporate and working capital purposes, it said in a statement. Shares had ended the regular session down 1.3%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 05/18/2017 14:49:10

    Halozyme shares fall after secondary share offering annoucned

    Halozyme Therapeutics Inc. shares fell in the extended session Thursday after the cancer-drug biotech company said it was launching a secondary offering of its stock. Halozyme shares fell 8.9% to $12.90 after hours. The company said it plans to offer $100 million in shares, or about 7.1 million shares based on Thursday's closing price. Underwriters Wells Fargo Securities and Deutsche Bank Securities will get the option for another $15 million in shares to cover overallotments. Halozyme said it will use proceeds to fund cancer-drug development and general corporate purposes. Halozyme has 129.8 million shares outstanding and in 2016 reported a loss of 81 cents a share on revenue of $146.7 million.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 05/16/2017 14:04:52

    Ford, Rite Aid Dip into Tuesday’s 52-Week Low Club


  • 05/15/2017 14:40:45

    Einhorn's Greenlight shaves position in Apple, adds to GM

    David Einhorn's Greenlight Capital reduced its stake in Apple Inc. while increasing its stake in General Motors Co. , according to a Securities and Exchange Commission filing late Monday. Greenlight reported holding 4.2 million shares of Apple, down from about 6.1 million shares in the previous quarter. The firm increased its stake in GM to 55 million shares from about 13 million in the previous quarter. Greenlight also reduced positions in IAC/Interactive Corp. , Rite Aid Corp. , and Time Warner Inc. , while taking new positions in Micron Technology Inc. and Perrigo Co. . Greenlight also increased its stake in Yahoo Inc. and dumped its position of Yelp Inc. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/19/2017 12:31:03

    FTC Seen as Set to Block Rite Aid Deal

    Shares of Rite Aid (RAD), Fred's (FRED) and Walgreens were hit Wednesday on rumors that the Federal Trade Commission is leaning towards filing a lawsuit seeking to block Walgreens planned acquisition of Rite Aid Corp. (RAD) Rite Aid (RAD) shares were down 22 cents from the morning's open to $4.25 in early afternoon trading, or almost 5%. Fred's (FRED) fell 91 cents to $14.14, or 8.6%. Walgreens edged down 1% from a high of $8...

  • 04/10/2017 14:20:56

    SEC targets fake stock news on financial websites

    (Reuters) - The U.S. Securities and Exchange Commission on Monday announced a crackdown on alleged stock promotion schemes in which writers were secretly paid to post hundreds of bullish articles about public companies on financial websites.

  • 04/05/2017 12:34:29

    The Market Just Doesn’t Believe in the Rite Aid Merger with Walgreens


  • 04/03/2017 14:04:23

    First Solar, Rite Aid Dip into Monday’s 52-Week Low Club


  • More trends:

    RLI Corp.RLI | RLJ Lodging TrustRLJ | Roadrunner Transportation SystemsRRTS | Robert Half International Inc.RHI | Rockwell AutomationROK | Rockwell CollinsCOL | Rogers CommunicationRCI | Rogers CorporationROG | RollinsROL | Roper TechnologiesROP |